Safety of Pharmaceutical Excipients and Regulatory Issues

Christian De Muynck, Claude Cuvelier, Danny Van Steenkiste, Luc Bonnarens, Jean Paul Remon, Rectal mucosa damage in rabbits after subchronical application of suppository bases. Pharmaceutical Research. ,vol. 8, pp. 945- 950 ,(1991) , 10.1023/A:1015828201697

D J Brancato, Recognizing potential toxicity of phenol Veterinary and Human Toxicology. ,vol. 24, pp. 29- 30 ,(1982)

Mannucci A, Pifferi G, Drug impurities: problems and regulations. Bollettino chimico farmaceutico. ,vol. 138, pp. 500- ,(1999)

A. Hertrampf, H. Müller, J.C. Menezes, T. Herdling, Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined. International Journal of Pharmaceutics. ,vol. 495, pp. 447- 458 ,(2015) , 10.1016/J.IJPHARM.2015.08.098

Kevin E. Bove, Michael K. Farrell, William F. Balistreri, Lessons from the E-Ferol tragedy. Pediatrics. ,vol. 78, pp. 503- 506 ,(1986)

Shan-Yang Lin, Yoshiaki Kawashima, The influence of three poly(oxyethylene)poly(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin. Pharmaceutica Acta Helvetiae. ,vol. 60, pp. 339- 344 ,(1985)

R. E. Brown, Andrew Paquet, Solomon L. Alade, Polysorbate 80 and E-Ferol Toxicity Pediatrics. ,vol. 77, pp. 593- 597 ,(1986)

R. Michael E. Richards, James Z. Xing, Kirsty M. B. Mackay, Excipient interaction with cetylpyridinium chloride activity in tablet based lozenges. Pharmaceutical Research. ,vol. 13, pp. 1258- 1264 ,(1996) , 10.1023/A:1016084824877

Ran D. Goldman, Adam Cheng, Seen Chung, Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation. Canadian Family Physician. ,vol. 55, pp. 481- 482 ,(2009)

Gilles Dumortier, Jean Louis Grossiord, Florence Agnely, Jean Claude Chaumeil, A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharmaceutical Research. ,vol. 23, pp. 2709- 2728 ,(2006) , 10.1007/S11095-006-9104-4